StockData
Valneva SE logo

Valneva SE (VALN) stock

VALNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 17, 2026Score 1/30
$5.34−0.23 (-4.04%)

Close on Nov 18, 2026Market cap $463.35MP/E –Yield –

Valneva price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Valneva's price to sales ratio was 3.5× on Nov 11, 2026, against 3.1× a year earlier. Over the last 3 years it ranged from 1.5× to 23.5×, with a median of 3.5×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20263.5×+0.0
2025Oct 31, 20253.5×+0.3
2024Apr 30, 20243.1×+1.5
2023Apr 28, 20231.6×−0.4
2022Oct 31, 20222.0×−18.2
2021Dec 31, 202120.2×–

More Valneva figures

See a number that looks wrong?